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ORIGINAL RESEARCH

Cardiorespiratory Fitness and the Risk of First Acute Myocardial
Infarction: The HUNT Study
Rajesh Shigdel, MPH, PhD; H
avard Dalen, MD, PhD; Xuemei Sui, MD, MPH, PhD; Carl J. Lavie, MD; Ulrik Wisløff, PhD;
Linda Ernstsen, RN, PhD

Background-—The majority of studies evaluating cardiorespiratory ﬁtness (CRF) as a cardiovascular risk factor use cardiovascular
mortality and not cardiovascular disease events as the primary end point, and generally do not include women. The aim of this
study was to investigate the association of estimated CRF (eCRF) with the risk of ﬁrst acute myocardial infarction (AMI).
Methods and Results-—We included 26 163 participants (51.5% women) from the HUNT study (Nord-Trøndelag Health Study), with a
mean age of 55.7 years, without cardiovascular disease at baseline. Baseline eCRF was grouped into tertiles. AMI was derived from
hospital records and deaths from the Norwegian Cause of Death Registry. We used Fine and Gray regression modeling to estimate
subdistribution hazards ratio (SHR) of AMI, accounting for competing risk of death. During a mean (range) follow-up of 13 (0.02–15.40)
years (347 462 person-years), 1566 AMI events were recorded. In fully adjusted models men in the 2 highest eCRF had 4% (SHR: 0.96,
95% CI: 0.83–1.11) and 10% (SHR: 0.90, 95% CI: 0.77–1.05) lower SHR of AMI, respectively, when compared with men in the lowest
tertile. The corresponding numbers in women were 12% (SHR: 0.88, 95% CI: 0.72–1.08) and 25% (SHR: 0.75, 95% CI: 0.60–0.95).
Conclusions-—eCRF was inversely associated with risk of AMI event among women but not in men. Our data suggest that high
eCRF may have substantial beneﬁt in reducing the risk of AMI. Therefore, our data suggest that an increased focus on eCRF as a
cardiovascular disease risk marker in middle-aged and older adults is warranted. ( J Am Heart Assoc. 2019;8:e010293. DOI: 10.
1161/JAHA.118.010293.)
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C

ardiovascular diseases (CVDs) are the number 1 cause of
morbidity and mortality worldwide.1–3 Acute myocardial
infarction (AMI) is among the most frequent underlying causes
of hospital admissions among older adults,4 and the increasing number of older people is expected to result in a
substantial increase in AMI incidence, healthcare demands,
and premature mortality.1,5
Cardiorespiratory ﬁtness (CRF) refers to the ability of the
circulatory and respiratory system to supply oxygen to
skeletal muscles during sustained physical activity (PA) and
it is considered as a key marker of cardiovascular health.6,7

Several prospective cohort studies have reported a consistent, inverse association between CRF and CVD events,6,8–11
CVD mortality,12 and all-cause mortality6,7,13–21 even after
adjustment for potential risk factors. Furthermore, most of
studies evaluating the association between CRF and fatal/
non-fatal CVD events are limited to men.8,10,22–24 However,
CVD is more common in women than in men, and more
knowledge on CVD risk in women is needed.25
A study on the association between CRF and risk of AMI
(non-fatal and fatal) in healthy Finnish men (aged 42–60
years) observed a strong inverse association between CRF
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What Is New?
• Data from the Nord-Trøndelag Health Study showed that
cardiorespiratory ﬁtness is associated with decreased risk
of ﬁrst myocardial infarction.
• Higher level of cardiorespiratory ﬁtness is even more
protective against incident myocardial infarction in middleaged and older women than in men.

What Are the Clinical Implications?
• Middle-aged and older adults, especially women, need to be
informed about the cardioprotective effects from higher
levels of cardiorespiratory ﬁtness.
• Cardiorespiratory ﬁtness is an important measurement that
can be easily estimated in routine clinical practices with
efforts to increase ﬁtness in patients with low levels as a
strategy to prevent a ﬁrst heart attack.
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and AMI.26 Another study of 43 356 Americans aged 20 to
84 years (21% women) from the Aerobic Center Longitudinal
Study also found an inverse association between CRF and
non-fatal CVD events (deﬁned as AMI, stroke, or coronary
revascularization procedure, self-reported from 65% to 75%
respondents).13 Unfortunately, previous studies did not report
separate results for AMI for either women or men. Whether
the protective effect from high CRF persists in relationship to
risk for AMI (non-fatal and fatal) in women and men from the
general population has not been previously evaluated. Thus,
long-term follow-up studies are needed to evaluate the
association between CRF and AMI that includes both sexes.
We therefore aimed to investigate the prospective association
between CRF and ﬁrst AMI in middle-aged and older men and
women from a large Norwegian population-based study.

Methods
Data from the HUNT study (Nord-Trøndelage Health study)
used in research projects will, when reasonably requested by
others, be made available upon request to the HUNT data
Access Committee (hunt@medisin.ntnu.no). The HUNT data
access information (available here https://www.ntnu.edu/
hunt/data) describes in detail the policy on data availability.

The HUNT Study
The HUNT study is one of the largest health studies ever
performed.27 The surveys called HUNT1, HUNT2, and HUNT3
were conducted in 1984 to 1986, 1995 to 1997, and 2006 to
2008, respectively. In all the HUNT surveys, the data were
collected in each of the 24 municipalities in the county
DOI: 10.1161/JAHA.118.010293

Nord-Trondelag by using temporarily located health examination sites staffed by certiﬁed ﬁeldwork teams. HUNT has largely
been publicly funded.28 For HUNT2 all residents of NordTrøndelag County, aged ≥20 years (reaching 20 years during
the year of the screening in their municipality) were invited to
the health survey.27 Detailed information about the HUNT can
be found elsewhere.27,28 HUNT data are linked to the unique
personal identiﬁcation number assigned to every Norwegian
citizen at birth. This makes it possible to link data between the
HUNT surveys and the Norwegian Cause of Death Registry. In
Norway, all deaths are required to be reported by a physician to
the National Cause of Death Registry with a cause of death
diagnosis.29 The ofﬁcial cause of death statistics are based on
these death certiﬁcates and are prepared in accordance with
the International Classiﬁcation of Diseases, Tenth Revision (ICD–
10). The Norwegian Institute of Public Health has been
responsible for processing data for the Causes of Death
Registry since 2001.29
The present study is a part of a project on middle-aged and
older people, thus 42 313 middle-aged and older individuals
who did not die until after they reached the age of 50 years in
HUNT2 were selected. The exclusion criteria included the
following: participants who reported ischemic heart disease or
stroke (n=4983) at baseline, and those with missing values on
ischemic heart disease or stroke (n=648); those who were
underweight (body mass index <18.5 kg/m2) (n=150); those
with missing data on the exposure variables for estimated
CRF (eCRF) or those who had missing information on any of
the potential confounders (n=10287). After this exclusion,
26 163 participants (51.5% women and 48.5% men) free from
CVD and with complete data on physical activity (PA), waist
circumference (WC), resting heart rate (rHR) and the
confounders that were included in the ﬁnal analyses
(Figure 1).

Cardiorespiratory ﬁtness
A non-exercise prediction model developed from HUNT2 was
used to determine non-exercise estimated cardiorespiratory
ﬁtness (eCRF)18 in the current study. The sex-speciﬁc
algorithms used in our cohort from HUNT2 were developed
from data collected in the HUNT Fitness study (2006–2008).
This sub-study was designed to obtain normal values from
VO2peak in a healthy population through a maximal treadmill
test and 4631 participants in the age range 19 to 90 years
participated. The participants also went through clinical
examinations and provided self-reported information through
several questionnaire as a part of the ordinary HUNT3 study.
Because the difference in the questions on PA in HUNT1
(1984–1996) and HUNT2 (1995–1997) participants in HUNT3
were asked about their PA level by the use of the questions
used in the 2 former HUNT surveys. And for the same reason
it has been developed different prediction models for nonJournal of the American Heart Association
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105:91  ð0:334  AgeÞ  ð0:402  WCÞ  ð0:144
 rHRÞ þ ð3:102  PAÞ

Women:
78:00  ð0:297  AgeÞ  ð0:270  WCÞ  ð0:110  rHRÞ
þ ð2:674  PAÞ
WC were measured to the nearest cm, horizontally at the
level of the umbilicus with the participants standing and
arms hanging relaxed. The rHR was measured by palpating
the radial pulse over a period of 15 seconds with a stopwatch, after at least 4 minutes of seated rest. PA was
measured as the weekly average of hours of PA the past
year and was measured through the question “How has your
leisure-time physical activity been the last year?” with 1
answering category for light PA (not sweating/not being out
of breath) and 1 for moderate/vigorous (sweating and being
out of breath). The 4 response options were “none,” “less
than an hour,” “1–2 hours” and “3 hours or more.” The
participants were classiﬁed as physically active if they met
the recommended weekly level of 150 minutes of moderate
PA, 75 minutes of vigorous PA, or a combination of both.30
These PA question have been validated against directly
measured cardiorespiratory ﬁtness and accelerometer
data.30

Downloaded from http://ahajournals.org by on April 20, 2020

65,237 (20–90+ years old)
Total participants in HUNT2
Excluded
22,924 Not meeting criteria due to age
limit, or death before they reach 50 years
of age

42,313 Middle aged and older
individuals who did not die
until after they reached the age
of 50 years of age

26,163 study cohort
(12,700 men, 13,463 women)

Excluded
4983 History of ischemic heart disease,
stroke
648 Missing values for ischemic heart
disease, stroke
150 Body mass index <18.5
82 Missing values for body mass index
10287 Missing values for
estimated
cardiorespiratory fitness, age, hypertension,
total cholesterol, smoking, diabetes
mellitus, family history of CVD, alcohol,
education, marital status or any limiting
long-term illness.

Figure 1. Participant ﬂowchart. CVD indicates cardiovascular death. HUNT, The Nord-Trøndelag Health
Study.
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exercise estimation of CRF from the HUNT population, where
1 includes the 3 PA questions on intensity, frequency, and
duration used in HUNT1 and HUNT3. The other model
includes the 2 PA question from HUNT2 on weekly duration
of hard PA (being sweat and breathless) and light PA (not
being sweat and breathless).18 According to the authors,18
the accuracy of the last model is comparable with the ﬁrst
model, and both non-exercise models have been validated
against CVD mortality where the results have been published.18,19 As the cohort in the current study consists of
middle-aged and older people who participated in HUNT2, we
used the sex-speciﬁc non-exercise algorithms based on the
PA questions from HUNT2. These algorithms predict CVD
mortality beyond the inclusion of classical CVD risk factors.18
Several other studies using non-exercise prediction models
also support the association between eCRF and cardiovascular health,13,20 and mortality.19,20
The sex-speciﬁc model consists of age, WC, PA and rHR.
The following algorithms were used to calculate each
individual’s eCRF:
Men:

Cardiorespiratory Fitness
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Assessment of covariates
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In HUNT2 information was collected through self-reported
questionnaires and clinical measurements, and the objective
and methods are previously described in detail by Holmen
et al27 Height and weight were measured with the participants
wearing light clothes without shoes, height to the nearest
1.0 cm and weight to the nearest 0.5 kg. Resting systolic and
diastolic blood pressure were measured by specially trained
nurses or technicians using a Dinamap 845XT (Critikon) based
on oscillometry. Blood pressure and heart rate were measured
automatically 3 times at 1-minute intervals. Blood pressure
reported is the mean of the second and third systolic and
diastolic blood pressures. Hypertension was deﬁned as
systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg or as self-report of current use of antihypertensive medication. According to European guidelines for CVD
prevention,31 the concentration of total cholesterol was
measured in accordance with the standards of the Centers
for Disease Control and Prevention’s Lipid Standardization
Program.27 Other covariates such as, smoking (current,
former, non-smoker), diabetes mellitus (yes, no), family history
of CVD (no, yes, I don’t know), alcohol drinking past 14 days
(abstainers, 0 times or not abstainers, 1–4 times, ≥5 times),
marital status (unmarried, married, widow, divorced), limiting
long-term illness (no, yes) were collected from questionnaires.
Data on the highest achieved education level were based on
the 1995 census and retrieved from the Norwegian Standard
Classiﬁcation of Education by Standard Classiﬁcation of
Education32 and categorized into 3 education levels: primary
(primary and lower secondary school), secondary (upper
secondary and post-secondary school) and tertiary (ﬁrst and
second stage of tertiary education).

First AMI
The Nord-Trøndelag county are served by 2 local hospitals only
in addition to 1 invasive center at the regional Trondheim
University Hospital, all patients admitted to the hospital in
central Norway will be included in the regional (from 2012–
2013 national) AMI registry. Thus, only patients not admitted
to the regional hospitals because of death out of hospital or
being admitted to hospitals in other health regions or countries
may be missing. For patients admitted to other Norwegian
hospitals the local hospitals will receive the reports, and if the
event was an AMI the patient will be included in the registry.
Even patients admitted to foreign hospitals with AMI would
most often be followed by the local hospitals and included in
the registry. AMI patients dying out of hospital do not have any
data in the registry, but these patients will be registered with
DOI: 10.1161/JAHA.118.010293

AMI as the cause of death. Naturally, the diagnostic accuracy
(AMI as the cause of death) may not be as valid as the inhospital AMIs as the diagnostic workﬂow differ. As for other
countries, the validity of the cause of death may be suboptimal.33 The validation process was done in 2 steps. First, all
AMIs are entered in to the registry by the caregiving
cardiologist or physician. All AMI diagnoses from the hospitals
are followed by an obligatory registration by the caregiving
cardiologist or physician. If the diagnosis is judged not to be
valid, the event is deleted from the registry. Secondly, we have
validated >50% of all AMIs from 1995, and of these, 97% have
been judged as valid AMIs by experienced cardiologists
(according to the third universal deﬁnition of MI.
Incidence of AMI was identiﬁed through linkage with
medical records from the 2 hospitals of Nord-Trøndelag
county. AMI was deﬁned and diagnosed by the caregiving
cardiologist and physicians according to the European
Society of Cardiology/American College of Cardiology
consensus guidelines.34 Criteria for AMI included: speciﬁc
clinical symptoms according to case history information,
changes in blood levels of cardiac enzymes, and ECG
changes as deﬁned in American and European consensus
guidelines.34,35 Some of the AMI diagnosis from the medical
records have been validated,36 and an ongoing validation
study (unpublished) found that 92% of the cases (n=1194)
was type 1 AMI, implying that the underlying pathological
process is plaque erosion, ﬁssuring, or rupture with
thrombus formation.37 Using the unique 11-digit identiﬁcation number of Norwegian citizens, individual information
was linked to the Norwegian Cause of Death Registry.
International Classiﬁcation of Diseases, Ninth Revision (ICD–
9), code 410; (ICD–10) codes I21, I22, and I23. The date of
the ﬁrst non-fatal AMI events was deﬁned as the date of
admission to hospital. The date of a fatal AMI event was
deﬁned as the date of death on the death certiﬁcate. In
participants with >1 non-fatal events, the earliest event was
used for analysis. Each of the 26 163 participants was
followed from the date of participation in HUNT2 (1995–
1997) to the date of hospital admission, death, emigration,
and/or until study end, 27th December 2010. In the current
study, the number of deaths from AMI were 319 and 1175
were non-fatal AMI.

Ethical Considerations
Ethical approval for the HUNT study was provided by the Data
Inspectorate of Norway and recommended by the Regional
Committee for Medical Research Ethics. Participation in the
HUNT study was voluntary, and each participant signed a
written consent about the use of data for research purpose.
The study was conducted in conformity with the Declaration
of Helsinki, 1964.
Journal of the American Heart Association
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The participants were further classiﬁed into eCRF tertiles;
low, medium, and high groups based on age (10-year
categories) and sex.
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Participant’s baseline characteristics are summarized as
mean, standard deviation, numbers, and percentages by
eCRF categories. We used 2 approaches to evaluate the
hazards of AMI attributable to each level of eCRF, we used 2
approach : 1) Cox proportional hazards regression model that
treat mortality as censored observation; and 2) We also
performed a competing risk analysis using Fine and Gray
survival modeling38,39 to estimate unadjusted and multivariable adjusted subdistribution hazard ratio (SHR) and 95% CIs
for ﬁrst AMI accounting for non-CVD death as a competing
risk. Due to the high competing risk of non-CVD death among
elderly people we presented main results are based on the
competing risk analysis. We presented both univariate and
multivariable adjusted models, and in the multivariable model,
we adjusted for age (in years), education (low, medium, high)
marital status (unmarried/married/widow/divorce), diabetes
mellitus (yes/no), any limiting-long standing illness (yes/no),
smoking (current smoker/former smoker/non-smoker), alcohol drinking past 14 days (abstainers, 0 times or not
abstainers, 1–4 times, ≥5 times), hypertension (yes/no),
hypercholesterolemia (yes/no), and family history of CVD
(yes/no). Confounders were adjusted based on previous
studies,10,13,24 and available data.
We also examined eCRF as a continuous variable so that
each SHR represents the risk associated with a 1-metabolic
equivalent (MET 3.5 mL/kg per min) increase in the exposure
variable. Person-time for each participant was computed from
the date of the baseline examination to the date of report of
ﬁrst AMI, death, emigration or to December 27, 2010.
Incidence rates were calculated as the number of cases
divided by person-time follow-up separately in men and
women. There was signiﬁcant statistical interaction between
the sex and eCRF in relation to AMI (P<0.05), we therefore,
stratiﬁed the analyses according to sex. The assumption of
proportionality was based on Schoenfeld residuals. The
proportionality of the model as a whole, and for each variable,
was checked. One of the confounders (family history of CVD)
was not proportional, so we stratiﬁed on the non-proportional
confounder. Data analyses were performed using STATA
statistical analyses software package (version 14; Stata Corp.)
A 2-sided P≤0.05 was accepted to indicate statistical
signiﬁcance.

Multiple imputations
The primary analyses were repeated using multiple imputations for the variables with missing information at baseline
using chained equation (MICE) under the assumption that
data were missing at random.40 We introduced a wide range
of variables into the imputation modes, which we thought
could predict incomplete variables. Fifteen duplicate
DOI: 10.1161/JAHA.118.010293

completed data sets were created in order to reduce sampling
variability from the imputation simulation. Parameter estimates from analyzing the imputed data sets were pooled
according to Rubin’s rules.41 However, the result based on
multiple imputation data (n=31 155) did not differ as
compared with complete case analyses. Our main results
are based on complete case analyses whereas multiple
imputation-based analyses are displayed in Table S1.

Results
Baseline Characteristics
The mean age (SD) of participants was 55.7 (11.4) years and
51.5% were women. Mean age (SD) of men and women were
55.8 (11.2) and 55.6 (11.6) years, respectively. During a
mean (range) of 13 (0.02–15.40) years (347 462 personyears) of follow up of exposure, there were 1566 incident
AMI events. The death rate from AMI in our sample was
1.67 per 1000 for men and 0.96 per 1000 for women.
Table 1 presents baseline characteristic of study participants
by eCRF categories stratiﬁed by sex. Mean low eCRF for
men was 36.6 mL/kg per min range (13.6–46.8) and
28.1 mL/kg per min range (10.1–38.0) for women. As
expected, men and women with low eCRF had higher body
mass index, WC, systolic and diastolic blood pressure than
those with medium and high eCRF levels. During the followup 3226 non-CVD related deaths were recorded (1446
women and 1780 men.

Incident AMI
The incidence rate of AMI was 506 per 18, 2366 person-years
for women and 1060 per 16, 5096 person-years for men.
There was an inverse association between eCRF and incident
AMI rates (Figure 2).

Association Between CRF and AMI with
Competing Mortality
eCRF and AMI in total cohort
Table 2 presents the association between eCRF and AMI in
total cohort. In unadjusted analysis, (model 1), those with
medium and high eCRF had 16% (SHR; 0.84; 95% CI, 0.75–
0.95) and 31% (SHR; 0.69; 95% CI, 0.61–0.78) lower rates of
AMI, than those who had low eCRF, respectively. This
inverse association remains statistically signiﬁcant for those
with high eCRF in the fully adjusted model. In the
multivariable analysis, those with medium and higher eCRF
had 7% (SHR; 0.93; 95% CI, 0.82–1.05) and 15% (SHR; 0.85;
95% CI, 0.75–0.97) lower rates of AMI, than those who had
low eCRF, respectively.
Journal of the American Heart Association
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Men (n=12 700)

Women (n=13 463)

Variables

Low eCRF Level,
(n=4150)

Medium eCRF Level,
(n=4259)

High eCRF Level,
(n=4291)

Low eCRF Level,
(n=4391)

Medium eCRF Level,
(n=4485)

High eCRF Level,
(n=4587)

Age, y

56.4 (11.1)

56 (11.3)

55.1 (11.3)

56.5 (11.6)

55.8 (11.6)

54.8 (11.6)

Height, cm

177.8 (6.6)

177 (6.5)

176 (6.4)

163.7 (6.2)

163.7 (6)

163.3 (6)

Weight, kg

88.3 (13.5)

83.9 (10.8)

79.1 (8.6)

80.7 (12.8)

69.7 (8.7)

63.5 (7.5)

BMI, kg/m2

29.2 (3.4)

26.4 (2.4)

24.7 (3.3)

30.1 (4.6)

26 (3)

23 (2.6)

WC, cm

100.8 (7.8)

92.3 (5.1)

85.7 (5.4)

92.8 (10.3)

81.1 (6.8)

73.9 (5.9)

Resting heart rate, bpm

75.9 (12.9)

67.9 (10.3)

61.3 (9.5)

78.7 (13.2)

72.0 (10.7)

66.7 (9.5)

eCRF (peak oxygen consumption
mL/kg per min)

36.6 (5.56)

42.0 (4.5)

46.8 (4.7)

28.1 (5.1)

32.7 (4.5)

36.5 (4.4)

eCRF (MET)

10.4 (1.6)

12.0 (1.3)

13.4 (1.3)

8.0 (1.5)

9.3 (1.3)

10.4 (1.3)

No

2889 (69.6)

1914 (45)

765 (18)

3448 (78.5)

2575 (57.4)

1092 (23.8)

Yes

1261 (30.4)

2345 (55)

3526 (82.2)

943 (21.5)

1910 (42.6)

3495 (76.2)

Current

1210 (29.1)

1241 (29.1)

1181 (27.5)

1294 (29.5)

1315 (29.3)

1290 (28.1)

Former

1800 (43.4)

1691 (39.7)

1427 (33.3)

1021 (23.2)

1098 (24.5)

1070 (23.3)

Non smoker

1140 (27.5)

1327 (31.2)

1683 (39.2)

2076 (47.3)

2072 (46.2)

2227 (48.6)

354 (8.5)

353 (8.3)

350 (8.2)

911 (20.7)

710 (15.8)

651 (14.2)

0 times, not abstainers

1018 (24.5)

921 (21.6)

891 (20.8)

1708 (38.9)

1529 (34.1)

1428 (31.1)

1 to 4 times

2246 (54.1)

2329 (54.7)

2385 (55.6)

1576 (35.9)

1945 (43.4)

2062 (44.9)

5 times

532 (12.8)

656 (15.4)

665 (15.5)

196 (4.5)

301 (6.7)

446 (9.7)

Weekly recommended PA, n (%)

Smoker, n (%)

Alcohol consumption, n (%)
Abstainers
Downloaded from http://ahajournals.org by on April 20, 2020

Diabetes mellitus, n (%)
No

3978 (95.9)

4147 (97.4)

4211 (98.1)

4209 (95.9)

4391 (97.9)

4537 (98.9)

Yes

172 (4.1)

112 (2.6)

80 (1.9)

182 (4.1)

94 (2.1)

50 (1.1)

No

2837 (68.4)

3135 (73.6)

3298 (76.9)

2918 (66.4)

3266 (72.8)

3591 (78.3)

Yes

1313 (31.6)

1124 (26.4)

993 (23.1)

1473 (33.6)

1219 (27.2)

996 (21.7)

No

1374 (33.1)

1889 (44.4)

2428 (56.6)

1698 (38.7)

2451 (54.7)

2963 (64.6)

Yes

2776 (66.9)

2370 (55.6)

1863 (43.4)

2693 (61.3)

2034 (45.3)

1624 (35.4)

Low

460 (11.1)

586 (13.8)

761 (17.7)

459 (10.5)

608 (13.6)

887 (19.34)

High

3690 (88.9)

3673 (86.2)

3530 (82.3)

3932 (89.5)

3877 (86.4)

3700 (80.6)

Systolic

145.8 (20.1)

141.7 (19)

137.8 (18.5)

145.5 (23.3)

138.3 (22.8)

133.2 (21.5)

Diastolic

88.2 (11.3)

84.8 (10.6)

81.5 (10.2)

84.8 (12.2)

80.6 (11.1)

77.3 (10.8)

No

2235 (53.9)

2340 (54.9)

2333 (54.4)

2118 (48.2)

2248 (50.1)

2316 (50.5)

Yes

1648 (39.7)

1675 (39.3)

1719 (40.1)

2028 (46.2)

2028 (45.2)

2084 (45.4)

Limiting long-term illness, n (%)

Hypertension, n (%)

Total cholesterol (mmol/L), n (%)

Blood pressure, mm Hg

Family history of CVD, n (%)

Continued
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Table 1. Baseline Characteristics of Middle-Aged and Older Participants in the Nord-Trøndelag Health Study 2 (1995–1997) by
Sex and eCRF Group in Tertiles
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Table 1. Continued
Men (n=12 700)

Women (n=13 463)

Low eCRF Level,
(n=4150)

Medium eCRF Level,
(n=4259)

High eCRF Level,
(n=4291)

Low eCRF Level,
(n=4391)

Medium eCRF Level,
(n=4485)

High eCRF Level,
(n=4587)

267 (6.4)

244 (5.7)

239 (5.57)

245 (5.6)

209 (4.7)

187 (4.1)

Primary

1325 (31.9)

1137 (26.7)

968 (28.2)

1754 (40)

1479 (33)

1277 (27.8)

Secondary

2275 (54.8)

2374 (55.7)

2323 (33.3)

2168 (49.4)

2268 (50.6)

2206 (48.1)

Tertiary

550 (13.3)

748 (17.6)

1000 (43.5)

469 (10.7)

738 (16.5)

1104 (24.1)

Unmarried

503 (12.1)

392 (9.2)

414 (9.6)

231 (5.3)

192 (4.3)

229 (5.0)

Married

3121 (75.2)

3384 (79.5)

3442 (80.2)

3161 (72.0)

3313 (73.9)

3381 (73.7)

Widow

188 (4.5)

127 (3.0)

121 (2.8)

638 (14.5)

594 (13.2)

560 (12.2)

Divorced

338 (8.1)

356 (8.4)

314 (7.3)

361 (8.2)

386 (8.6)

417 (9.1)

Variables

I don’t know
Education, n (%)

Marital status, n (%)

Values are presented as mean (SD), number (n), percentage (%) of participants. BMI indicates body mass index; bpm, beats per minute; CVD, cardiovascular disease; eCRF, estimated
cardiorespiratory ﬁtness; MET, metabolic equivalent; WC, waist circumference.

eCRF and AMI in men
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In unadjusted analysis, (model 1), men with medium and high
eCRF had 11% (SHR; 0.89; 95% CI, 0.77–1.02) and 25% (SHR;
0.75; 95% CI, 0.65–0.88) lower rates of AMI, than men who
had low eCRF, respectively. This inverse association did not
remain statistically signiﬁcant in the fully adjusted model. In
the multivariable analysis, men with medium and higher eCRF
had 4% (SHR; 0.96; 95% CI, 0.83–1.11) and 10% (SHR; 0.90;
95% CI, 0.77–1.05) lower rate of ﬁrst AMI, than men who had
low eCRF, respectively.
Unadjusted analysis exhibited a 23% lower risk of ﬁrst AMI
for each 1-unit higher MET (SHR; 0.77; 95% CI, 0.75–0.79).
After adjustment of all confounders, each 1-unit MET increase
was associated with 3% lower rate of ﬁrst AMI (SHR; 0.97;
95% CI, 0.92–1.01).

eCRF and AMI in women
In unadjusted analyses (Table 2), women with medium and
high eCRF had 25% (SHR; 0.75; 95% CI, 0.62–0.93) and 44%
(SHR; 0.56; 95% CI, 0.45–0.70) lower risk of ﬁrst AMI than
women with low eCRF, respectively. In multivariable analysis,
women with medium and high level of eCRF had 22% (SHR;
0.88; 95% CI, 0.72–1.08) and 25% (SHR; 0.75; 95% CI, 0.60–
0.95) lower risk of ﬁrst AMI than women who had low eCRF,
respectively.
Unadjusted analysis exhibited a 41% lower risk of ﬁrst AMI
for each 1-unit higher MET (SHR; 0.59; 95% CI, 0.56–0.61). In
multivariable analysis, each 1-unit MET increase was associated with 11% lower risk of ﬁrst AMI (SHR; 0.89; 95% CI,
0.82–0.96).
There was a similar substantial increase in the estimated
hazard ratio (HR) of AMI when using traditional Cox regression
DOI: 10.1161/JAHA.118.010293

versus competing risk model. (Table 2) Using the competing
risk approach (Figure 1), the absolute probability of AMI was
higher among those with low eCRF and medium eCRF as
compared with those with high eCRF in both men and women.

Discussion
In this prospective study of a general population, we observed
that women with high CRF had a protective effect against AMI
as compared with those with low eCRF level, even after
adjustment for well-known CVD risk factors and other
potential confounders.
The ﬁndings of the present study are in agreement with
previous research in the general population, which demonstrates that higher level of measured CRF is associated with a
lower risk of CVD outcomes,8,15 including AMI.11,13,26,42 Our
ﬁndings based on traditional analytical approach (Cox
proportional hazard regression) are also in line with previous
ﬁndings from the HUNT cohort18 and the National Health and
Nutrition Examination Survey,21 which reports a statistical
signiﬁcant inverse association between estimated CRF from
non-exercise algorithms and CVD mortality in men and
women. However, CVD mortality is not quite comparable
with ﬁrst AMI, where also ﬁrst non-fatal CVD events are
included, meaning that our results are better suited for
assessing disease risk. To our knowledge, this is the ﬁrst
study to show the association between eCRF and risk of ﬁrst
AMI making use of information of both non-fatal and fatal
events in men and women.
Artero et al13 found that both medium and high eCRF was
associated with lower CVD related mortality and non-fatal
CVD in men. In women, only high eCRF was signiﬁcantly
Journal of the American Heart Association
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Total

eCRF

Cox Proportional Hazards Models

Fine and Gray, Sub Distribution Models

HR (95% CI)

SHR (95% CI)

Non-fatal/fatal AMI

Model 1

Model 2

Model 1

Model 2

Low

434/169

1 (Ref)

1 (Ref)

1 (Ref)

1 (Ref)

Medium

401/125

0.83 (0.74–0.93)

0.90 (0.80–1.01)

0.84 (0.75–0.95)

0.93 (0.82–1.05)

High

340/97

0.66 (0.59–0.75)

0.81 (0.71–0.92)

0.69 (0.61–0.78)

0.85 (0.75–0.97)

P linear trend

<0.001

<0.05

<0.001

<0.05

Maximal oxygen uptake, mL/kg per min

0.95 (0.95–0.96)

0.98 (0.97–0.99)

0.96 (0.95–0.97)

0.99 (0.97–0.99)

Per 1 MET

0.85 (0.83–0.87)

0.93 (0.90–0.97)

0.87 (0.85–0.89)

0.95 (0.92–0.99)

Men (n=12 700)
Low

288/102

1 (Ref)

1 (Ref)

1 (Ref)

1 (Ref)

Medium

282/78

0.87 (0.76–1.01)

0.93 (0.80–1.07)

0.89 (0.77–1.02)

0.96 (0.83–1.11)

High

247/63

0.73 (0.63–0.85)

0.87 (0.74–1.01)

0.75 (0.65–0.88)

0.90 (0.77–1.05)

P linear trend

<0.001

0.067

<0.001

0.195

Maximal oxygen uptake, mL/kg per min

0.91 (0.90–0.92)

0.98 (0.97–0.99)

0.93 (0.92–0.93)

0.99 (0.98–1.00)

Per 1 MET

0.72 (0.70–0.74)

0.95 (0.91–0.99)

0.77 (0.75–0.79)

0.97 (0.92–1.01)

Women (n=13 463)
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Low

146/67

1 (Ref)

1 (Ref)

1 (Ref)

1 (Ref)

Medium

119/47

0.74 (0.60–0.91)

0.85 (0.69–1.04)

0.75 (0.62–0.93)

0.88 (0.72–1.08)

High

93/34

0.55 (0.44–0.68)

0.71 (0.56–0.88)

0.56 (0.45–0.70)

0.75 (0.60–0.95)

P linear trend

<0.001

<0.05

<0.001

<0.05

Maximal oxygen uptake, mL/kg per min

0.84 (0.83–0.85)

0.96 (0.94–0.98)

0.86 (0.85–0.87)

0.97 (0.94–0.99)

Per 1 MET

0.54 (0.52–0.57)

0.87 (0.80–0.94)

0.59 (0.56–0.61)

0.89 (0.82–0.96)

Model 1: Unadjusted. Model 2: Adjusted for age, education, marital status, diabetes mellitus, any limiting-long standing illness, smoking, alcohol intake, hypertension,
hypercholesterolemia, family history of CVD. eCRF indicates estimated cardiorespiratory ﬁtness; HUNT, The Nord-Trøndelag Health Study; MET, metabolic equivalent; Ref, Reference group;
SHR, subdistribution hazard ratio.

associated with non-fatal CVD risk (HR; 0.38; 95% CI, 0.22–
0.70). However, in their study, neither medium (HR; 0.70; 95%
CI, 0.35–1.37) or high (HR; 0.65; 95% CI, 0.32–1.31) eCRF
were statistically signiﬁcantly associated with CVD-related
mortality in women. The reasons for this dissimilarity to our
ﬁnding might be because of differences in the population
characteristics, and relatively low statistical power in their
study, as there was a smaller number of CVD-related mortality
(50/9145) and non-fatal CVD cases (72/3635) among
women. Moreover, in the former study, the assessment of
incidence of non-fatal CVD was based on self-report while
non-fatal AMI events in our study were identiﬁed through
medical diagnoses from hospital records. In the current study,
we observed that the risk for ﬁrst AMI decreased more with
higher levels of CRF among women than for men. It appears
that women gain more beneﬁt than men in the reduction of
AMI when increasing CRF from low to medium levels. In
support of our ﬁndings previous literature reports that
differences between men and women emerge when PA
DOI: 10.1161/JAHA.118.010293

increase beyond low intensity.43 Similarly, a meta-analysis
shows that the relative risk for coronary disease reduce more
rapidly with a lower level of PA for women than for men.44 A
recent prospective study of 29, 854 male participants from
the Aerobics Center Longitudinal Study found that those with
high eCRF had a 28% (HR=0.72; 95% CI 0.57, 0.91) lower
CHD-mortality risk compared with those with low eCRF.
However, no association was found among men with moderate eCRF.45
Our data underscore that substantive protective effect
against incident AMI can be achieved among women even by
maintaining high eCRF (5–12 MET). However, in our study
high levels of eCRF were not statistically signiﬁcant associated with protection against incident AMI among men. In
addition, when eCRF, was deﬁned as a continuous variable,
we observed 3% and 5% lower risk of AMI for each 1-unit
increase in MET in men and women, respectively. These
associations were in agreement with previous ﬁndings
showing13,18,21 that for each MET of higher eCRF there was
Journal of the American Heart Association
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Table 2. Subdistribution Models and Tradition Cox Proportional Hazards Models for Association of Different Categories of eCRF
With Risk of AMI in Middle-Aged and Older Men and Women Participating in HUNT2 (1995–1997), 15.4 Years’ Follow-Up
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Figure 2. Cumulative absolute probability of AMI by eCRF categories using cumulative incidence function
(competing risk approach). AMI indicates acute myocardial infarction; eCRF, estimated cardiorespiratory
ﬁtness.
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an 18% to 25% lower risk for CVD mortality in men and 15% to
25% lower risk in women even after adjusting for age, clinical
risk factors, lifestyle factors, and disease status. A metaanalysis showed that the risk reduction associated with 1-MET
higher non-exercise eCRF was 13% and 15% for all-cause and
CVD mortality, respectively.17 However, this meta-analysis did
not report sex-speciﬁc results. Data from the National Health
and Nutrition Examination Survey III showed that each 1-MET
higher eCRF was associated with a 19% and 24% lower CVD
mortality hazard risk in men and women, respectively,
suggesting that the protective effect was slightly larger
among women as observed in our study. The higher risk
reduction in the National Health and Nutrition Examination
Survey III study compared with the present study could be
explained by their inclusion of individuals with existing heart
disease and cancer.
The speciﬁc casual mechanism of lower risk for ﬁrst AMI
among those with high eCRF remains to be investigated.
However, it is known that both genetic and behavioral factors
inﬂuence levels of CRF.46 The contribution of genetic factors
on CRF is estimated to vary from 20% to 40%47,48 thus,
modiﬁable factors such as PA, body composition, and lifestyle
factors play potentially important roles to maintain CRF.49
Several physiological and metabolic mechanisms favorable to
cardiovascular health have been explained in previous
reports.12,21,24 Biological plausibility for the presented
DOI: 10.1161/JAHA.118.010293

association may be through PA with high eCRF leads to
lower blood pressure, lower level of serum lipids, cholesterol,
and inﬂammation markers like interleukin, C-reactive protein
and several other factors,50 which predispose to development
of AMI.
The main strength of the present study lies in the
prospective design and large representative sample size of
middle-aged and older individuals. To our knowledge, this is
the ﬁrst and largest study to relate the association of eCRF
with ﬁrst AMI accounting for the competing risk in asymptomatic middle-aged and older men and women. We believe
that previous studies failing to account for competing risk
may have overestimated CVD risk among the older population, as there is evidence that Cox regression models may
overestimate the risk if incorrectly used in the presence of
competitive risk.39
Additionally, the HUNT cohort is recognized for having valid
data and a high participation rate.28 The eCRF was calculated
by using non-exercise algorithms developed from the same
cohort, which can provide a better estimation of CRF. We have
reliable data on AMI as the major outcome, which were
prospectively ascertained by medical records from the 2
hospitals of the Nord-Trøndelag County and cause-speciﬁc
deaths from the Norwegian Cause of Death Registry. We
excluded those with CVD at baseline and broad ranges of
potential confounders were taken into account in the
Journal of the American Heart Association
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Conclusions
eCRF, estimated by using easily available health indicators was
strongly associated with lower risk of ﬁrst AMI in women when
accounting for competing risk of mortality. The eCRF could be
useful in the routine clinical practice as a feasible means to
estimate CRF and to predict the AMI risk in the general population.
Population-based interventions designed to reduce CVD risk
should promote smoking cessation and PA, to maintain ideal
weight and to increase or maintain high eCRF levels.
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analyses. However, there are some limitations in our study.
PA, the main variable in the algorithm, was self-reported, and
people could tend to overestimate PA. Furthermore, we
calculated the eCRF at baseline but the variation in PA and
other components that are used to determine eCRF might
have occurred over this follow-up period thus, potentially
leading to an underestimation of the study association. There
may be some residual confounding, such as, information
about diet and medications were not available. Non-response
bias is a concern in epidemiologic surveillance, and participation in HUNT2 was strongly age-dependent, with the
highest participation in the age group, 60 to 69 years, for
both sexes (84.3% in men and 87.0% in women), and gradually
lower participation rate in younger and older age groups.27
Heavy alcohol drinker and people with mental distress were
also less likely to participate in HUNT2.51 As the population of
the HUNT study is homogeneous with respect to ethnicity and
genetics, the ﬁndings of this study have high internal validity,
but this may limit generalization to other populations with
different ethnicity. Clearly, further studies are needed to
investigate the association of eCRF with AMI in other cohorts.
Although CRF is an important risk marker for AMI, it is not
routinely measured in the clinical practice because of the high
associated costs, time and requirement of trained personnel
and specialized equipment. Therefore, eCRF obtained from
non-exercise algorithms can be a more cost-effective way of
assessing CRF for the wide use in the routine clinical
practice.18,52 Moreover, eCRF can be calculated by using
easily available health indicator variables, many of which are
potentially available in electronic health records. Therefore,
eCRF could potentially add clinical value in routine clinical
practice as a simple tool to identify individuals who are at high
risk of ﬁrst AMI. In fact, last year a scientiﬁc statement from
the American Heart Association underscores the importance
of assessing CRF in clinical practice as a clinical vital sign.
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